111 related articles for article (PubMed ID: 15841317)
1. Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells.
May AE; Schmidt R; Bülbül BO; Hölderle M; Walther F; Schömig A; Gawaz M; Klouche M
Thromb Haemost; 2005 Apr; 93(4):710-5. PubMed ID: 15841317
[TBL] [Abstract][Full Text] [Related]
2. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
[TBL] [Abstract][Full Text] [Related]
5. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
6. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
[TBL] [Abstract][Full Text] [Related]
7. Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin.
Houard X; Monnot C; Dive V; Corvol P; Pagano M
J Cell Biochem; 2003 Apr; 88(6):1188-201. PubMed ID: 12647301
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes.
Ardans JA; Economou AP; Martinson JM; Zhou M; Wahl LM
J Leukoc Biol; 2002 Jun; 71(6):1012-8. PubMed ID: 12050187
[TBL] [Abstract][Full Text] [Related]
9. Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2.
Zhang Y; Wahl LM
J Leukoc Biol; 2006 Jan; 79(1):105-13. PubMed ID: 16244112
[TBL] [Abstract][Full Text] [Related]
10. Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.
Wilson D; Massaeli H; Pierce GN; Zahradka P
Mol Cell Biochem; 2003 Jul; 249(1-2):141-9. PubMed ID: 12956409
[TBL] [Abstract][Full Text] [Related]
11. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration.
Zhao B; Luo X; Shi H; Ma D
Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846
[TBL] [Abstract][Full Text] [Related]
13. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K
Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696
[TBL] [Abstract][Full Text] [Related]
14. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
16. An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature.
Lehti K; Allen E; Birkedal-Hansen H; Holmbeck K; Miyake Y; Chun TH; Weiss SJ
Genes Dev; 2005 Apr; 19(8):979-91. PubMed ID: 15805464
[TBL] [Abstract][Full Text] [Related]
17. Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression.
Beaudeux JL; Said T; Ninio E; Ganné F; Soria J; Delattre J; Soria C; Legrand A; Peynet J
Clin Chim Acta; 2004 Jun; 344(1-2):163-71. PubMed ID: 15149885
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.
Haug C; Lenz C; Díaz F; Bachem MG
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1823-9. PubMed ID: 15319264
[TBL] [Abstract][Full Text] [Related]
19. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
Shah PK; Falk E; Badimon JJ; Fernandez-Ortiz A; Mailhac A; Villareal-Levy G; Fallon JT; Regnstrom J; Fuster V
Circulation; 1995 Sep; 92(6):1565-9. PubMed ID: 7664441
[TBL] [Abstract][Full Text] [Related]
20. Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II.
Dab H; Hachani R; Dhaouadi N; Hodroj W; Sakly M; Randon J; Bricca G; Kacem K
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):36-45. PubMed ID: 22071631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
